Table 3 Correlation analyses between clinicopathological factors and total length of copy number aberrations in breast cancers.
| Â | Mean total length of copy number aberrations (bp) | |||
|---|---|---|---|---|
Clinical factors | All cases (n = 28) | A-bomb survivors (n = 15) | ||
| Â | r* | P -value* | r* | P -value* |
Age at the time of diagnosis | -0.37 | 0.055 | -0.59 | 0.021 |
Tumor size (cm) | 0.042 | 0.83 | -0.25 | 0.37 |
Storage time (years) | 0.35 | 0.064 | 0.49 | 0.067 |
DLRSpread | -0.40 | 0.034 | -0.38 | 0.16 |
Age of the time of exposure to the A-bomb** | Â | Â | -0.31 | 0.25 |
Exposure distance from the hypocenter (km)** | Â | Â | 0.11 | 0.70 |
Time between age at diagnosis and exposure (year)** | Â | Â | -0.52 | 0.047 |